Trademark: TAVALISSE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for TAVALISSE
We do not have any records of a proof of use for TAVALISSE at this moment.
Possible trademark infringements of TAVALISSE
Basic Information about TAVALISSE
- Serial Number
- 87407547
- Filing Date
- 11 Apr 2017
- Registration Number
- 5822266
- Registration Date
- 30 Jul 2019
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of TAVALISSE on the blockchain with WikiTrademarks.io.
- First use of TAVALISSE anywhere
- TAVALISSE was first used on 30 Apr 2018 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns TAVALISSE?
1. Rigel Pharmaceuticals, Inc. South San Francisco CA
2. Rigel Pharmaceuticals, Inc. San Francisco CA
3. Rigel Pharmaceuticals, Inc. San Francisco CA
Correspondent
- James J. Saul FAEGRE DRINKER BIDDLE & REATH LLP
- 320 South Canal Street, Suite 3300
- Chicago, IL 60606
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io